In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bioenvision Inc.

Division of Sanofi
www.bioenvision.com

Latest From Bioenvision Inc.

OrbiMed Closes $550 Million Fund

OrbiMed Advisers just closed a $550 million fund, a tick more than its previous general fund and raised mostly from previous backers. OrbiMed’s general partners say they’ll make no radical departures from their previous formula despite the upheaval brought on by the recession and the federal health care reform saga.
BioPharmaceutical Medical Device

Are Share Buybacks a Wise Investment for Biopharma

Biogen Idec, Genzyme and Amgen have eached announced large share buybacks recently. Wall street smiles on these buybacks and the conventional wisdom suggests they are a tax-efficient way of returning cash to shareholders. But in biopharmaceuticals, there is a downside to these shareholder sweeteners.
BioPharmaceutical Business Strategies

Activist Shareholders Complicate Buyout Math

The efforts of an increasingly vocal group of activist shareholders, including Carl Icahn, Matrix Asset Advisors, Third Point, ValueAct, and Baker Brothers Advisors, to flush out the interest of strategic buyers has become compelling and increasingly commonplace.
BioPharmaceutical Business Strategies

Deals Update (05/2007)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • Christopher B Wood, MD, Pres. & CEO
    James S Scibetta, CFO
    MaryJane Rafii, VP, Reg. Affairs
  • Contact Info
  • Bioenvision Inc.
    Phone: (212) 750-6700
    509 Madison Ave., Ste. 404
    New York, NY 10022
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register